Home Loan Rates Inch Up Past 6.5% Amid Rising Oil Prices

Source: Yahoo Finance (Global)
Arth Insight · What this means for your wallet
- Your monthly home loan payment (EMI) will likely increase.
- Borrowing more money for a home will become more expensive.
- Existing borrowers with floating rates may see their EMIs go up.
Mortgage interest rates in India are showing signs of increasing, with some lenders now offering rates above 6.5%. This trend is partly influenced by the recent surge in global oil prices, which can impact inflation and borrowing costs.
- ▸Home loan interest rates are starting to cross the 6.5% mark.
- ▸Rising global oil prices are a key factor contributing to potential rate hikes.
- ▸Higher EMIs mean increased costs for new and existing borrowers.
- ▸Shopping around for the best loan offers is crucial in this environment.
- ✓Home loan interest rates are starting to cross the 6.5% mark.
- ✓Rising global oil prices are a key factor contributing to potential rate hikes.
- ✓Higher EMIs mean increased costs for new and existing borrowers.
- ✓Shopping around for the best loan offers is crucial in this environment.
Homebuyers in India might need to adjust their budgets as mortgage interest rates begin to edge upwards. Several lenders have reportedly started offering home loans at rates exceeding 6.5% per annum. This uptick is a notable shift from the recent period of relatively stable and competitive home loan pricing.
Factors Influencing Rate Hikes
The primary driver behind this upward movement appears to be the recent volatility in global commodity markets, particularly the jump in crude oil prices. When oil prices rise significantly, it often leads to increased inflation across the economy. Central banks, including the Reserve Bank of India (RBI), may respond to rising inflation by tightening monetary policy, which can translate into higher interest rates for various forms of credit, including home loans.
While the RBI has maintained a steady repo rate for some time, the broader economic environment and liquidity conditions can still influence the rates offered by commercial banks and housing finance companies. Increased operational costs for lenders, driven by inflation, could also be a contributing factor to the revised interest rates.
Impact on Homebuyers
For prospective homebuyers, an increase in mortgage rates means a higher Equated Monthly Instalment (EMI) for the same loan amount. This could potentially reduce purchasing power or necessitate a larger down payment. For instance, a loan of ₹50 lakh taken for 20 years at 6.5% would have an EMI of approximately ₹36,850. If the rate increases to 7%, the EMI for the same loan would rise to around ₹38,770, an increase of nearly ₹2,000 per month.
Existing borrowers with floating interest rate home loans may also see their EMIs increase if their loan is repriced based on the new, higher benchmark rates. It is advisable for borrowers to review their loan statements and understand how any potential rate hike might affect their monthly outgoings.
Navigating the Current Market
As interest rates begin to climb, it becomes even more crucial for individuals to shop around for the best home loan offers. Comparing interest rates, processing fees, and other charges from various banks and financial institutions can lead to significant savings over the loan tenure. Additionally, understanding the loan structure, such as the option to switch between fixed and floating rates, could be beneficial.
While the current trend suggests a slight increase, the overall interest rate environment in India remains competitive compared to historical levels. However, potential homebuyers should factor in the possibility of further rate adjustments when planning their property purchases and financial commitments.
This article is for informational purposes only and does not constitute financial advice.
Loan interest rates, processing fees and eligibility are set by the lender and subject to credit approval — verify current terms before applying. Some listings may be sponsored. Not financial advice.
Frequently Asked Questions
Why are home loan rates increasing?
Home loan rates are influenced by various factors, including the repo rate set by the RBI, inflation, and global economic conditions like rising oil prices, which can lead lenders to increase their borrowing costs.
How will rising interest rates affect my EMI?
If interest rates rise, your Equated Monthly Instalment (EMI) for a home loan will also increase, meaning you pay more each month for the same loan amount.
What should I do if my EMI increases?
If your EMI increases, review your budget to accommodate the higher payment. You might also consider pre-paying a portion of your loan or exploring options to switch lenders if a better rate is available.
Join the Arth Vani channels
Daily news summaries, IPO & market alerts on Telegram and WhatsApp.
Because you read about real-estate

Indian Healthcare Philanthropy Surges 82% to ₹1,768 Crore in FY26
Philanthropic contributions to India's healthcare sector surged by 82% to ₹1,768 crore in FY26, according to the EdelGive Hurun India Philanthropy List 2026. This significant growth positions healthcare as the second-most favored cause for donors, with 175 philanthropists participating.

Lord's Mark Industries Reports ₹82 Crore H1 FY27 Profit; Eyes AI Healthcare Expansion by 2027
Lord's Mark Industries Ltd has reported a consolidated net profit of ₹82.01 crore for the first half of the financial year 2026-27 (FY27). The company also announced plans to launch innovative AI-powered healthcare products, including dialysis machines and Sickle Cell screening solutions, by early 2027.
IPOBreakingAragen Life Sciences to Invest ₹1,500 Crore in Expansion Ahead of ₹800 Crore IPO
Aragen Life Sciences has announced a ₹1,500 crore capital expenditure plan over the next three years to boost its drug development and manufacturing capacity. The company is preparing for its stock market debut, which includes a fresh issue of shares worth ₹800 crore.
Related Stories

Indian Healthcare Philanthropy Surges 82% to ₹1,768 Crore in FY26
Philanthropic contributions to India's healthcare sector surged by 82% to ₹1,768 crore in FY26, according to the EdelGive Hurun India Philanthropy List 2026. This significant growth positions healthcare as the second-most favored cause for donors, with 175 philanthropists participating.

Lord's Mark Industries Reports ₹82 Crore H1 FY27 Profit; Eyes AI Healthcare Expansion by 2027
Lord's Mark Industries Ltd has reported a consolidated net profit of ₹82.01 crore for the first half of the financial year 2026-27 (FY27). The company also announced plans to launch innovative AI-powered healthcare products, including dialysis machines and Sickle Cell screening solutions, by early 2027.
IPOBreakingAragen Life Sciences to Invest ₹1,500 Crore in Expansion Ahead of ₹800 Crore IPO
Aragen Life Sciences has announced a ₹1,500 crore capital expenditure plan over the next three years to boost its drug development and manufacturing capacity. The company is preparing for its stock market debut, which includes a fresh issue of shares worth ₹800 crore.

Biocon Secures USFDA Approval for Breast Cancer Biosimilar Pebrilzo
Indian biopharmaceutical major Biocon Ltd has received approval from the US Food and Drug Administration (USFDA) for its biosimilar Pebrilzo, a treatment for HER2-positive breast cancer. This milestone expands Biocon's US oncology biosimilar portfolio to five products, with a global launch agreement with Genentech set for 2028.